The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Mirati Therapeutics, in collaboration with additional groups including Monoceros Biosystems, [...]
Monoceros Biosystems: Bringing Professional Grade Bioinformatics to All
Monoceros Biosystems has been selected as a top 10 bioinformatics [...]
Monoceros Biosystems, a top bioinformatics/computational biology industry partner, is pleased to announce the appointment of John Lamb, PhD and Dan Rawlins, JD to its Advisory Board
Monoceros Biosystems LLC is pleased to announce that John Lamb, [...]